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Abstract
Background: Accumulation of gyrase cleavage complex in Escherichia coli from the action of quinolone antibiotics
induces an oxidative damage cell death pathway. The oxidative cell death pathway has also been shown to be
involved in the lethality following accumulation of cleavage complex formed by bacterial topoisomerase I with
mutations that result in defective DNA religation.
Methods: A high copy number plasmid clone spanning the upp-purMN region was isolated from screening of an
E. coli genomic library and analyzed for conferring increased survival rates following accumulation of mutant
topoisomerase I proteins as well as treatment with the gyrase inhibitor norfloxacin.
Results: Analysis of the intergenic region upstream of purM demonstrated a novel mechanism of resistance to the
covalent protein-DNA cleavage complex through titration of the cellular transcription regulators FNR and PurR
responsible for oxygen sensing and repression of purine nucleotide synthesis respectively. Addition of adenine to
defined growth medium had similar protective effect for survival following accumulation of topoisomerase
cleavage complex, suggesting that increase in purine level can protect against cell death.
Conclusions: Perturbation of the global regulator FNR and PurR functions as well as increase in purine nucleotide
availability could affect the oxidative damage cell death pathway initiated by topoisomerase cleavage complex.
Background
DNA topoisomerases catalyze topological transforma-
tions of DNA by concerted breaking and rejoining of
DNA strands via the formation of a covalent complex
between the enzyme and cleaved DNA [1]. While the
activities of topoisomerases are critical for vital cellular
functions, topoisomerase enzymes are also vulnerable
targets for cell killing because DNA rejoining by topoi-
somerases can often be inhibited by antibacterial or
anticancer agents that are referred to as topoisomerase
poisons [2,3]. Quinolones are widely used antibacterial
drugs that lead to the accumulation of covalent cleavage
complex formed by the bacterial type IIA topoisome-
rases, DNA gyrase and topoisomerase IV [4,5]. The
accumulation of DNA gyrase covalent complex from the
action of quinolones has been shown to induce an
oxidative damage cell death pathway in E. coli as at least
one of the potential mechanisms of cell killing [6-9].
The sequence of events following topoisomerase clea-
vage complex accumulation that leads to generation of
reactive oxygen species remains unclear.
Although a specific poison for bacterial topoisomerase
I remains to be identified, accumulation of topoisome-
rase I cleavage complex in E. coli has also been shown
to lead to rapid cell death from the study of topoisome-
rase I mutants defective in DNA rejoining [10,11]. Simi-
lar to gyrase cleavage complex, topoisomerase I cleavage
complex accumulation in E. coli induces the SOS
response via the RecBCD pathway [12]. Increase in reac-
tive oxygen species has been shown to also contribute to
the cell death pathway initiated by accumulation of
topoisomerase I cleavage complex [13]. Recombinant E.
coli and Yersinia pestis topoisomerase I mutants that
accumulate the covalent cleavage complex due to defi-
ciency in DNA rejoining provide useful model systems
for studying the physiological effect of topoisomerase-
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somerase I (YpTOP1) is highly homologous to E. coli
topoisomerase I, with the advantage of its dominant
lethal recombinant clones being more stable in E. coli
than comparable E. coli topoisomerase I mutant clones.
The Y. pestis mutant topoisomerase I model system has
been utilized to screen for E. coli genomic clones, that
when present in high copy number on a plasmid, can
confer resistance to topoisomerase cleavage complex
induced cell killing. Additional experiments on an iso-
lated clone demonstrated a novel mechanism of
increased resistance to topoisomerase cleavage complex
via titration of the transcription factors FNR and PurR
by a high copy number plasmid clone of the intergenic
region between upp and purM. This plasmid clone also
increased bacterial resistance to norfloxacin that induces
the accumulation of the type IIA topoisomerase covalent
cleavage complex. FNR regulates transition between
anaerobic and aerobic conditions [14,15]. Genome-wide
expression analysis has previously shown that FNR con-
tributes to the repression of a number of genes induced
by oxidative stress conditions [16,17]. PurR is a suppres-
sor of purine biosynthesis. Titration of the FNR and
PurR transcription factors by the high copy number
clone is expected to increase the expression level of
genes normally suppressed by these two regulators.
These results provide further insights into the oxidative
cell death pathways initiated by topoisomerase cleavage
complex accumulation.
Results
Isolation of clone pAQ5 containing the upp-purMN region
in selection for resistance to topoisomerase I cleavage
complex mediated cell death
After transformation of E. coli strain BW117N with the
E. coli genomic DNA library generated with the pCR-
XL-TOPO cloning system, four different plasmid clones
isolated from colonies obtained on LB plates with
0.002% arabinose were confirmed to increase resistance
to the dominant lethal effect of the mutant Y. pestis
topoisomerase I, YpTOP1-D117N [10]. Detailed analysis
of the clone pAQ5 containing the upp-purMN region of
E. coli chromosome (corresponding to nucleotides
2618398-2620765 of E. coli MG1655 sequence, Figure
1a) is described here. Strain BW117N is under strong
selective pressure to eliminate expression of the domi-
nant lethal mutant YpTOP1-D117N. Subsequent analy-
sis of the effect of clone pAQ5 or its derivatives was
therefore carried out with strain BW27784 carrying plas-
mid pAYTOP128 expressing YpTOP1 with the less
lethal G122S mutation that also leads to accumulation
of the topoisomerase I cleavage complex [11]. Clone
pAQ5 was found to increase survival following arabinose
induction of this mutant YpTOP1 by 63-fold compared
to the control empty vector (Table 1). This clone (Fig-
ure 1a) contains the entire purM (5’-phosphoribosyl-5-
aminoimidazole synthetase) coding sequence (2619219-
2620256), part of the purN (phosphoribosylglycinamide
formyltransferase) coding sequence (2620256-2620894),
and part of the upp (uracil phosphoribosyltransferase)
coding sequence (2618268-2618894), plus the intergenic
regulatory region between the upp and purMN genes
(2618946-2619178). Analysis of total cellular protein by
western blot showed that clone pAQ5 did not confer
resistance by decreasing the expression level of mutant
topoisomerase I after arabinose induction (Figure 2a).
Analysis of resistance to topoisomerase I cleavage
complex conferred by upp-purMN intergentic region
To determine the basis of resistance from clone pAQ5,
derivatives of pAQ5 were constructed by cloning of
specific PCR amplified DNA into pCR-XL-TOPO vec-
tor. These include clones pAQ5-1with purM and the
intergenic region, pAQ5-2 with uppA and the inter-
genic region, and pInter, with the intergenic region
a l o n e( F i g u r e1 a ) .T h e s ec l o n e sw e r et r a n s f o r m e di n t o
strain BW27784 containing pAYTOP128 expressing
mutant Y. pestis topoisomerase I deficient in DNA reli-
gation due to the TOPRIM G122S mutation to investi-
gate the effect of the clones on viability following
induction of mutant topoisomerase I. The results
(Table 1) showed that the intergenic region alone in
clone pInter was sufficient to confer resistance to the
mutant topoisomerase I. Western blot analysis con-
firmed that the protective effect of pInter was also not
due to reduction in expression level of mutant topoi-
somerase I (Figure 2b).
Examination of this intergenic sequence showed that it
includes the binding site sequences of two transcription
factors, FNR and PurR (Figure 1b). The FNR binding
sequence, TTGACTTTAGTCAA versus the TTGAT-
N4ATCAA consensus sequence [18-20], is located 61.5
nucleotides upstream of the upp transcription start site.
The PurR binding sequence, CGCAAACGTTTGCTT,
versus the consensus PurR operator sequence of
CGCAAACGTTTNCNT [21], is located 28 nucleotides
upstream of the purM gene. FNR acts as a dual tran-
scription regulator that activates certain genes required
for anaerobic growth and represses many genes required
for aerobic growth [22]. Its interaction with the upp-
purMN region has been reported previously [19]. PurR
negatively regulates the transcription of genes involved
in purine and pyrimidine nucleotide synthesis including
purMN [21,23,24]. We therefore hypothesize that the
high copy number pInter could titrate these transcrip-
tion factors to relieve the repression of other E. coli
genes encoded on the chromosome. To test this hypoth-
esis, these binding sites were eliminated individually by
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Figure 1 E. coli chromosomal DNA insert in high copy plasmid clone pAQ5 and its derivatives (a) Clone pAQ5 containing sequence in
the upp-purM-purN region was selected from an E. coli genomic DNA plasmid library for resistance to cell killing mediated by mutant
topoisomerase I YpTOP1-D117N expressed in BW117N. PCR was used to amplify the intergenic sequence shown in (b) for cloning into pCR-
TOPO-XL cloning vector in the construction of pInter. The sequence of the FNR and PurR binding site deleted in pInterD1 and pInterD2 is
shown in (c).
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TGACTTTAGTCA were deleted from the FNR binding
site to result in plasmid pInterD1. Nucleotides
AAACGTTTGCTT were deleted from the PurR binding
site to result in plasmid pInterD2. Measurement of cell
viability following induction of mutant topoisomerase
from pAYTOP128 showed that elimination of either of
these two binding sites reduced the protective effect of
pInter, (Table 1). Comparison of the growth curves of
these strains (Figure 2c) showed that while cells trans-
formed with pInter and pInterD1 grew to a lower den-
sity at saturation, the initial growth rates of these strains
are similar. The slightly slower growth rate of cells
transformed with pInterD1 was not statistically signifi-
cant and since pInterD1 conferred a lesser degree of
resistance than pInter, the difference in viability follow-
ing accumulation of topoisomerase I cleavage complex
cannot be accounted for simply as due to growth
inhibition.
Effect of high copy number plasmid clone pInter on
sensitivity to norfloxacin BW27784 transformed with
the high copy number plasmid clones pAQ5 or pInter
were treated with the gyrase inhibitor norfloxacin to
determine if the plasmids could confer resistance also to
cell death mediated by type II topoisomerase cleavage
complex. The results (Table 2) showed that these plas-
mids could confer ~30-fold higher survival rates than
the control vector. Deletion of either the FNR or PurR
binding site from pInter decreased the protective effect,
demonstrating that titration of these transcription fac-
tors could result in increased resistance to norfloxacin.
It should be noted that pInterD1 conferred more pro-
tection than pInterD2 to mutant topoisomerase I killing
(Table 1) and the opposite was true for norfloxacin kill-
ing (Table 2).
Table 1 Effect of high copy plasmid clones on survival
following accumulation of mutant topoisomerase I
cleavage complex
Plasmid Survival Ratio
pCRII vector 7.85 × 10
-5 ± 1.19 × 10
-5
pAQ5 4.95 × 10
-3 ± 1.55 × 10
-3
pAQ5-1 4.92 × 10
-3 ± 1.20 × 10
-3
pAQ5-2 1.25 × 10
-2 ± 2.48 × 10
-3
pInter 1.90 × 10
-2 ± 4.12 × 10
-3
pInterD1 4.22 × 10
-3 ± 1.02 × 10
-3
pInterD2 5.19 × 10
-4 ± 1.73 × 10
-4
E. coli BW27784 carrying pAYTOP128 was transformed with high copy number
plasmid shown in the table. Cultures were grown to exponential phase with
shaking, then treated with 0.002% arabinose for 2.5 h before serial dilution
and plating on LB plates with antibiotics and 2% glucose
Survival ratio was determined by calculating the ratio of the viable colony
counts obtained from the induced cultures versus the viable counts from non-
induced culture. The results represent the average and standard errors from
at least three experiments
A
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YpTOP
YpTOP*
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- +       - +    Arabinose
YpTOP
YpTOP*
Figure 2 Effect of plasmid clones on recombinant mutant Y.
pestis topoisomerase I expression and growth rates Western
blot analysis of expression of mutant Y. pestis topoisomerase I
in the presence of control vector and clone pAQ5 (a) or pInter
(b). Exponential phase cultures were treated with 0.002% arabinose
for 2.5 h. Total cellular protein was analyzed by SDS PAGE and
Western blot with mouse monoclonal antibodies against E. coli
topoisomerase I (EcTOP). This antibody recognizes the highly
homologous Y. pestis topoisomerase I (YpTOP) and its partially
degraded product (YpTOP*).(C) Growth of BW27784 transformed
with vector, pInter, pInterD1 and pInterD2 in LB. Absorbance was
measured in a 96 well microplate at 37°C every 20 min using the
Perkin Elmer 7000 Plus BioAssay Reader with the filter set at 590 nm
and shaking for 10 min before each measurement.
Table 2 Effect of high copy plasmid clones on survival
following treatment with norfloxacin
Plasmid Survival Ratio
pCRII vector 2.14 × 10
-5 ± 4.1 × 10
-6
pAQ5 7.57 × 10
-4 ± 2.14 × 10
-4
pInter 6.12 × 10
-4 ± 1.28 × 10
-4
pInterD1 8.41 × 10
-5 ± 3.55 × 10
-5
pInterD2 1.11 × 10
-4 ± 2.01 × 10
-5
E. coli BW27784 transformed with high copy number plasmid was grown to
exponential phase with shaking. Cultures were treated with 250 ng/ml
norfloxacin for 2 h before serial dilution and plating on LB plates with
kanamycin
Survival ratio was determined by calculating the ratio of the viable colony
counts obtained from the treated cultures versus the viable counts from
untreated culture. The results represent the average and standard errors from
at least three experiments
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The protective effect from titration of PurR could be
due to increased availability of purine nucleotides. This
was tested by growth of BW27784 transformed with
pAYTOP128 in minimal media. Greater than 3 logs of
loss of viability could be measured at 2 h after induction
of mutant topoisomerase I expression by 0.0002% arabi-
nose (Figure 3a). The presence of 100 μg/ml adenine in
the growth medium increased the number of viable
colonies by 30-fold at 2 h after arabinose addition. The
presence of adenine did not affect expression level of
mutant topoisomerase I as determined by western blot
(Figure 3B).
To determine if addition of adenine affects sensitivity
to norfloxacin, BW27784 cells grown in minimal med-
ium with different adenine concentrations were first
evaluated by examining growth inhibition by norfloxa-
cin. Increased resistance to growth inhibition by nor-
floxacin was observed in the presence of 250 μg/ml
adenine (Figure 4a). Growth of BW27784 in the
absence of norfloxacin was not affected significantly by
the presence of adenine. Viable colony counts at 3 h
after norfloxacin treatment were then measured and
found to be increased 24-fold by the presence of ade-
nine (Figure 4b).
A
B
YpTOP
YpTOP*
Figure 3 Addition of adenine to minimal medium increases
survival following induction of mutant topoisomerase I
cleavage complex BW27784 transformed with pAYTOP128 was
grown overnight in RM minimal medium with 2% glucose to
suppress mutant topoisomerase I expression, then diluted
1:100 into RM medium with 0.2% glycerol. When OD600 reached
0.4, 0.00008% or 0.0002% arabinose was added with or without 100
μg/ml adenine included. Viable colony counts were determined at 1
h and 2 h after arabinose addition (a). The presence of adenine did
not affect expression of mutant YpTOP after induction of 0.0002%
arabinose for 2 h as analyzed by Western blot (b).
Figure 4 Decreased sensitivity to norfloxacin from addition of
adenine BW27784 was grown overnight in RM minimal
medium with 0.2% glycerol and then diluted 1:100 and grown
to exponential phase.( a) The exponential phase culture was
diluted twofold with RM medium with (o) no addition, (+) 250 μg/
ml adenine, (Δ)120 ng/ml norfloxacin, or (◊)120 ng/ml norfloxacin
and 250 μg/ml adenine. Absorbance was measured at 37°C every
20 min using the Perkin Elmer 7000 Plus BioAssay Reader with the
filter set at 590 nm and shaking for 10 min before each
measurement. (b) Exponential phase culture was treated with 200
ng/ml norfloxacin with or without 250 μg/ml adenine along with
controls with no treatment or adenine alone. After 3 h at 37°C,
viable colony counts were determined by dilution and plating on
LB plates.
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the level of hydroxyl radicals following norfloxacin
treatment
T h eh i g hc o p yn u m b e rp I n t e rr e s u l t e di n~ 3 0 - f o l d
higher ratio of viability after treatment with norfloxacin
when compared to control plasmid with no insert
(Table 2). Bactericidal antibiotics have been shown to
initiate formation of reactive oxygen species in their cell
killing mechanism [7,8,25], and hydroxyl radicals forma-
tion has been shown to be involved in bacterial cell
death following topoisomerase I cleavage accumulation
[ 1 3 ] .W eh y p o t h e s i z et h a tt h eh i g hc o p yn u m b e ro ft h e
upp-purMN intergenic region modulates cellular meta-
bolism to reduce the formation of reactive oxygen spe-
cies upon accumulation of topoisomerase I cleavage
complex. Formation of hydroxyl radicals was followed
by increase in fluorescence intensity from reporter HPF
[7]. The results (Figure 5) showed that at 2 h after addi-
tion of 250 ng/ml of norfloxacin, HPF fluorescence
intensity from hydroxyl radicals in BW27784 cells trans-
formed with pInter was reduced compared to HPF
fluorescence from BW27784 transformed with vector
after drug treatment.
Effect of chromosomal fnr and purR mutations on
sensitivity to topoisomerase I cleavage complex
accumulation
To support the hypothesis that the protective effect
from pInter is due to the titration of the transcription
factors FNR and PurR, chromosomal mutations elimi-
nating the activity of the fnr and purR genes were intro-
duced into BW27784 by P1 transduction resulting in
strains IFL6 (Δfnr)a n dI F L 7(ΔpurR). Viable colony
counts were measured following induction of mutant
topoisomerase I expression from pAYTOP128. The
results showed that in agreement with the hypothesis,
higher rates of survivals were observed in the absence of
FNR or PurR activity, with a greater effect from the
purR mutation (Figure 6a). Western blot analysis was
used to confirm that the mutations did not affect induc-
tion of mutant topoisomerase I expression (Figure 6b).
It is consistent that PurR loss, either by purR mutation
shown in Figure 6a or titration by high copy of its bind-
ing site in pInterD1 and other plasmids shown in Table
1, increases resistance.
The protective effect of Δfnr mutation was greater under
low oxygen conditions
The genes suppressed by FNR directly or indirectly via
the sRNA FnrS [26,27] include many aerobic metabolic
genes as well as genes involved in removal of reactive
oxygen species such as katE, sodA and sodB [16].
Hydroxyl radicals generated from superoxide have been
shown to be involved in the cell killing pathway initiated
C
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Fluorescence (arbitrary units)
Vector, no drug
Vector , + norfloxacin
pInter, no drug
pInter, + norfloxacin
Figure 5 T h ep r e s e n c eo fp I n t e rd e c r e a s e dt h el e v e lo f
hydroxyl radicals present in norfloxacin-treated cells E. coli
BW27784 with control vector or pInter were grown to
exponential phase before treatment with 250 ng/ml
norfloxacin. HPF was added 2 h later for fluorescence detection of
hydroxyl radicals by flow cytometry. The results represent a single
experiment out of four independent experiments (p < 0.05 for
decrease in fluorescence after norfloxacin treatment due to the
presence of pInter).
A
B
Arabinose
YpTOP
YpTOP*
Figure 6 Effect of ΔpurR and Δfnr mutations on sensitivity to
topoisomerase I cleavage complex Strains BW27784 and its
isogenic derivatives IFL6 (Δfnr), IFL7 (ΔpurR) were transformed
with pAYTOP128 and grown in LB with shaking to exponential
phase before the addition of 0.002% arabinose.( a) Viable
colony counts of arabinose treated cultures were divided by the
colony counts from the untreated culture to obtain the survival
ratio. (b) Western blot analysis showed that the ΔpurR and Δfnr
mutations did not affect expression levels of mutant YpTOP after
induction with 0.002% arabinose for 2.5 h.
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cultures have been incubated with shaking at 215 rpm
in our experiments carried out so far. Gene regulation
by FNR is responsive to low level of oxygen [22,28]. We
therefore modified our experimental conditions to
decrease oxygen availability. BW27784 or IFL6 (Δfnr)
cells were grown without shaking in a closed vessel until
OD600 = 0.4. After addition of arabinose to induce
mutant topoisomerase I expressed by pAYTOP128, the
culture was divided into two portions and incubation
was continued with and without shaking. Measurement
of survival ratio (ratio of viable colonies compared to
control culture with no arabinose added) shown in
Table 3 indicated that for BW27784, the survival ratio
after induction of mutant topoisomerase I is higher in
culture without shaking (around tenfold), likely due to
lower level of reactive oxygen species. The protective
effect from the Δfnr mutation was more prominent
when oxygen was limiting versus when oxygen was
available. This is in agreement with the active role of
FNR in gene regulation under anaerobic conditions.
However, chromosomal ΔpurR and Δfnr mutations
w e r ef o u n dt oh a v el i t t l ee f f e c to nt h ev i a b l ec o l o n y
counts at 1 and 2 h after treatment with up to 250 ng/
ml norfloxacin (data not shown). Greater than 1000-fold
lower bactericidal rates were observed for BW27784
with oxygen limitation when compared to incubation
with oxygen after treatment with norfloxacin, in agree-
ment with previous report of decreased norfloxacin sen-
sitivity under anaerobic conditions [29]. It is therefore
not feasible to investigate any potential protective effect
from pInter or the Δfnr mutation under low oxygen
conditions.
Discussion
As e g m e n to fE. coli chromosomal DNA spanning the
upp-purMN region was selected from a high copy num-
ber plasmid library of E. coli genomic DNA fragments
based on its ability to confer resistance to cell killing
mediated by accumulation of topoisomerase I cleavage
complex. The intergenic region of upp-purMN was
found to protect against bacterial cell death initiated by
both type I and type II covalent topoisomerase-DNA
cleavage complex. Deletion of the binding sites for FNR
and PurR decreased the protective effect, suggesting that
the protective effect we observed for pInter resulted
from titration of the transcription regulators FNR and
PurR.
PurR is a repressor of purine biosynthesis in E. coli
[19]. The hypothesis that the protective effects observed
from the high copy number plasmid pInter is related to
purine nucleotide pool availability is supported by the
increased viability when adenine was added to defined
medium. The ΔpurR mutation resulted in up to 475-
fold higher survival rate following topoisomerase I cova-
lent cleavage complex accumulation. Although pInter
could increase survival rate following norfloxacin treat-
ment, the ΔpurR chromosomal mutation did not affect
norfloxacin sensitivity. Deletion mutation of a global
transcription regulator is likely to affect the many meta-
bolic genes under its regulation differently than titration
of the global transcription regulator by the presence of
its binding site on a high copy number plasmid. Chro-
mosomal PurR recognition sites with the strongest bind-
ing affinity for PurR might still be repressed by PurR
even in the presence of pInter but they would be
depressed in the ΔpurR background. The cell death
pathways initiated by type IA and type IIA topoisome-
rases may be affected to different degrees by the change
in metabolic gene expression resulting from ΔpurR
mutation. The level of cellular ATP and NAD
+/NADH
ratio are factors that could influence the induction of
the reactive oxygen species following accumulation of
the topoisomerase cleavage complex [7,8].
FNR is a global regulator for the response of many
genes to oxygen level [22,28]. It can activate or repress
different genes directly by binding to the upstream regu-
latory region [19]. FNR also activates the transcription
of the small non-coding RNA FnrS which negatively
regulates the expression of multiple genes, including
many that encode enzymes with functions linked to oxi-
dative stress [26,27]. The presence of its binding site on
pInter was responsible for part of the resistance to
topoisomerase I cleavage complex mediated cell killing
conferred by this high copy number plasmid. The oxy-
gen level in the culture decreased as cell growth
approached stationary phase even with shaking, probably
resulting in partial activity of the FNR protein. Regula-
tory effect of FNR on transcription of acetyl coenzyme
A synthetase gene in E. coli has been previously
observed under conditions that are not strictly anaerobic
[30]. We showed that the protective effect of the Δfnr
mutation on cell death following topoisomerase I
Table 3 Protective effect of Δfnr mutation for cell killing
initiated by mutant topoisomerase I cleavage complex
accumulation under aerobic and low oxygen conditions
Survival Ratio
Aerobic Low Oxygen
BW27784 1.18 × 10
-4 ± 7.7 × 10
-5 1.07 × 10
-3 ± 4.7 × 10
-4
IFL6 1.30 × 10
-3 ± 3.1 × 10
-4 8.15 × 10
-2 ± 3.1 × 10
-3
Δfnr effect 11-fold 76-fold
Cultures were grown to exponential phase without shaking, then treated with
0.002% arabinose for 2.5 h under either aerobic or low oxygen conditions
before serial dilution and plating on LB plates with antibiotics and 2%
glucose. Survival ratio was determined by calculating the ratio of the viable
colony counts obtained from the induced cultures versus the viable counts
from non-induced culture. The results represent the average and standard
errors from at least three experiments
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under low oxygen condition, consistent with the
increased activity of FNR expected when oxygen is limit-
ing. FNR may influence cell death pathway initiated by
topoisomerase cleavage complex by suppressing the
genes that can enhance the response to reactive oxygen
species implicated in the cell death pathway. Alterna-
tively, decrease in FNR activity may alter the metabolic
state of the cell, so that it is less susceptible to the oxi-
dative damage cell death pathway.
In future studies, it would be informative to express
FNR and/or PurR in the corresponding deletion mutants
under the control of an inducible promoter. This would
allow examination of promoter occupation across the
genome and correlate global gene expression pattern
with sensitivity to the oxidative damage cell death
pathway.
Methods
Bacterial strains and plasmids
Genomic DNA E. coli strain YT103 was used to gener-
ate the chromosomal fragment library. It has ydeA::kan
and Δara mutations to avoid having clones in the
library that are known to decrease expression from the
arabinose inducible BAD promoter [31]. Sensitivity to
topoisomerase I cleavage complex mediated cell death
was measured in E. coli strain BW27784 and its deriva-
tives. This genetic background allows uniform
expression of recombinant mutant topoisomerase I
under the control of the BAD promoter in response to
arabinose [32]. The YpTOP1-D117N clone with the
highly lethal Asp to Asn mutation at the first aspartate
of the TOPRIM DxDxxG motif [33] was integrated into
the chromosome in strain BW117N [10]. Mutant
YpTOP1 with the Gly to Ser mutation at position
G122S of the TOPRIM motif was expressed from plas-
mid pAYTOP128 [11]. Other chromosomal mutations
were introduced into E. coli BW27784 by P1 transduc-
tion. PCR amplification of specific E. coli chromosomal
fragments for cloning, and site-directed mutagenesis of
the plasmid encoded sequence, were carried out using
Pfu II Ultra DNA polymerase (from Stratagene). All
strains and plasmids used in this study are listed in
Table 4. LB medium was used for culture unless other-
wise stated.
Screening of clones conferring resistance to
topoisomerase I cleavage complex
E. coli YT103 chromosomal fragments, with sizes
between 2.5 and 4.5 kbp, generated from partial Sau3A1
digestion and sonication were gel purified and used to
g e n e r a t eah i g hc o p yn u m b e rp l a s m i dl i b r a r yw i t ht h e
pCR-XL-TOPO cloning system (Invitrogen). The pooled
plasmid library with >10,000 genomic DNA clones was
used to transform E. coli BW117N by electroporation.
Transformants that were resistant to the dominant
Table 4 E. coli strains and plasmids used in this study
Relevant genotype Source or construction
E. coli strains
BW27784 Δ(araBAD)567 Δ(rhaBAD)568 Yale E. coli Genetic Stock Center
Δ(araFGH) F(ΔaraEpPCP18-araE) [32]
BW117N BW27784 with chromosomally integrated YpTOP1-D117N gene [10]
AQ4335 Δara leu7697 NBRP NBRP-E. coli at NIG
FB20344 MG1655 ydeA::Tn5KAN-I-SceI U. Wisconsin [34]
YT103 AQ4335 ydeA::Tn5KAN-I-SceI P1(FB20344) × AQ4335, Kan
r
JW1328-1 Δfnr771::kan Yale E. coli Genetic Stock Center [35]
JW1650-1 ΔpurR746::kan Yale E. coli Genetic Stock Center [35]
IFL6 BW27784 Δ fnr771::kan P1(JW1328-1) × BW27784, Kan
r
IFL7 BW27784 Δ purR746::kan P1(JW1650-1) × BW27784, Kan
r
Plasmids
pAYTOP128 Mutant derivative of pAYTOP encoding YpTOP1 with G122S, M326V and A383P mutations [11]
pCRII High copy number cloning vector Invitrogen
pAQ5 pCR-XL-TOPO cloning product of E. coli chromosome fragment 2618398-2620765 This study
pAQ5-1 pCR-XL-TOPO carrying upp gene and the intergenic region of upp-purMN This study
pAQ5-2 pCR-XL-TOPO carrying purM gene and the intergenic region of upp-purMN This study
pInter pCR-XL-TOPO carrying the intergenic region of upp-purMN This study
pInterD1 pInter with the FNR binding site deleted This study
pInterD2 pInter with the PurR binding site deleted This study
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Page 8 of 10lethal effect of YpTOP1-D117N were selected by plating
on LB plates with antibiotics and 0.002% arabinose.
Plasmid was isolated from viable colonies and confirmed
in subsequent transformation of BW117N to confer
resistance to cell killing mediated by topoisomerase I
cleavage complex accumulation.
Cell viability assays
Transformants of BW27784 or BW117N were grown in
LB medium with antibiotics to exponential phase
(OD600 = 0.4). The cultures were treated with either ara-
binose to induce recombinant mutant topoisomerase I
or the gyrase inhibitor norfloxacin for the stated length
of time at 37°C with shaking at 215 rpm unless other-
wise stated. Serial dilutions of the cultures were then
plated on LB plates with antibiotics with 2% glucose
added for BW117N or BW27784 transformed with pAY-
TOP128, and incubated overnight. The viable colony
counts from the treated cultures were normalized
against the untreated culture to calculate the survival
ratio. The results shown represent the average and stan-
dard errors of at least three experiments.
Western blot analysis of recombinant Y. pestis
topoisomerase I expression
Exponential phase cultures were treated with indicated
concentration of arabinose for 2 or 2.5 h. Cells were col-
lected by centrifugation from volumes based on OD600
and resuspended in SDS gel sample buffer before boiling
for 5 min and SDS page for total protein analysis. The
coomassie blue stained gel was examined to confirm
equal loading. For improved control of equal loading in
experiments using minimal media, total soluble proteins
were prepared and quantitated by the BioRad Dc protein
assay. Mouse monoclonal antibodies against E. coli
topoisomerase I were used in Western blot analysis to
detect the highly homologous Y. pestis topoisomerase I.
Partially degraded Y. pestis topoisomerase I (YpTOP*)
was also detected.
Hydroxyl radicals formation assay
BW27784 transformed with vector or pInter was grown
to exponential phase in LB before treatment with 250
ng/ml norfloxacin, or left untreated as control. After the
indicated time, hydroxyl radicals were measured with
the fluorescent reporter dye, 3’(p-hydroxyphenyl) fluor-
escence (HPF) in a FACScan flow cytometer (Becton
Dickinson) [13].
Conclusions
We demonstrated that titration of the E. coli tran-
scription factors FNR and PurR by plasmid clones
with the transcription factor binding sites can confer
resistance to cell killing mediated by mutant
topoisomerase I cleavage complex and norfloxacin act-
ing on DNA gyrase. Our study showed that perturba-
tion of the global regulator FNR and PurR function as
well as increase in purine nucleotide availability, could
affect the oxidative damage cell death pathway
initiated by topoisomerase cleavage complex. The
metabolic state of the cell is likely to be an important
factor for the bactericidal outcome in this cell death
pathway.
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